Premium
Human capital gaps in vaccine development: an issue for global vaccine development and global health
Author(s) -
Cawein Andrea,
Emini Emilio,
Watson Michael,
Dailey Joanna,
Donnelly John,
Tresnan Dina,
Evans Tom,
Plotkin Stanley,
Gruber William
Publication year - 2017
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/nyas.13316
Subject(s) - scarcity , human capital , business , global health , economic growth , economics , health care , microeconomics
Despite the success of vaccines in reducing the morbidity and mortality associated with infectious diseases, many infectious diseases, both newly emerging and well known, lack vaccines. The global capability for beginning‐to‐end vaccine development has become limited, primarily owing to a scarcity of human capital necessary to guide the development of novel vaccines from the laboratory to the marketplace. Here, we identify and discuss the gaps in human capital necessary for robust vaccine development and make recommendations to begin to address these deficiencies.